Mammalian target of rapamycin in chronic liver disease and the potential for therapeutic manipulation
{{output}}
Chronic Liver Disease (CLD) represents a growing epidemic in the Western world, yet treatment options that effectively slow its progression remain limited. Mammalian target of rapamycin (mTOR) inhibitors, such as sirolimus (also known as rapamycin), have been ... ...
